When I set out to learn R, one question came up with almost every client and programmer I met — myself included: is R package validation actually required? Because of this burning question, I wanted to outline and explain in simple terms...
ADaM IN PRACTICE · A TECHNICAL SERIES FOR CLINICAL TRIAL STATISTICAL PROGRAMMERS CNSR, EVNTDESC, event and censor date algorithms, and the ADTTE traceability gaps that trigger information requests. Abstract Time-to-event datasets...
ADaM IN PRACTICE · A TECHNICAL SERIES FOR CLINICAL TRIAL STATISTICAL PROGRAMMERS Where ADaM ends and the CDISC Analysis Results Standard begins, and why building results metadata upstream changes how you structure ADaM in the first pla...
ADaM IN PRACTICE · A TECHNICAL SERIES FOR CLINICAL TRIAL STATISTICAL PROGRAMMERS How large studies end up with hundreds of parameters, and the naming, value-level metadata, and controlled terminology discipline that keeps define.xml ma...
CRO STATISTICAL PROGRAMMING DURING PUBLICATION WORK How database locks, analysis populations, and data cutoffs drift apart between the Clinical Study Report and the congress poster, and how to trace, attribute, and reconcile every numb...
ADaM IN PRACTICE · A TECHNICAL SERIES FOR CLINICAL TRIAL STATISTICAL PROGRAMMERS Abstract When an FDA reviewer picks a number from a submitted table and asks where it came from, the package must answer without the study team in the r...
TECHNICAL WHITE PAPER A governed, standards-driven workbench for reproducible clinical test data and auditable AI-generated SDTM transformation programs ABSTRACT A reproducible path from study intent to test-ready evidence Synt...
ADaM IN PRACTICE · A TECHNICAL SERIES FOR CLINICAL TRIAL STATISTICAL PROGRAMMERS Designing compliant custom ADaM datasets when the structure taxonomy breaks down, and documenting the rationale so validators and reviewers stay on your s...
The latest CDISC Library release deepens oncology coverage and pushes the 360i vision of AI-driven, metadata-first clinical research another step forward. CDISC has released the latest package of Biomedical Concepts (BCs) and SDTM Dat...
A working guide for statistical programmers: the build flow, the CDISC Library API, real-time study creation, and where it breaks Most of us learned the trade backwards. We collect data on a CRF designed by one team, receive it from an...
WHITEPAPER From Mapping Specification to Production Code A whitepaper on the ClinStandards Spec-to-Code Converter AI Tool Clinical programming is built on a deceptively simple promise: the study specification says what must be cr...
A guardrailed clinical table shell compiler for validated R and SAS output What the Tool Does TLF Compiler V2 supports a clinical programming workflow where table shells, AdaM metadata, and programming conventions must stay aligned...
A working reference for biostatisticians and statistical programmers GxP is shorthand for the family of regulations and quality guidelines that apply to any work that touches a regulated medicinal product. The G stands for Good, the x i...
A Statistical Programmer's Guide to RECIST 1.1, BOR, and CDISC Implementation 1. What is Objective Response Rate? Objective Response Rate (ORR) is the proportion of patients in a trial whose tumor burden shrinks by a pre-specif...
A Practitioner's Deep Dive with Worked Examples in SAS Why this matters GDPR has been in force since 25 May 2018. Most statistical programmers I work with still treat "anonymized" as a synonym for "I dropped the US...
CLINSTANDARDS.ORG Deep Dive Article PROC R | PROC PYTHON | PROC IML | PROC FCMP SASPy | {pharmaverse} | R Consortium FDA Submissions Pilots 1. Introduction: The Multi-Language Imperative in Clinical Trials For decades, SAS has been...
CLINSTANDARDS.ORG Mini Deep Dive What the SAS Viya 2026.03 Base SAS Procedures Guide Tells Us 1. The Big News: SAS Now Has PROC R With the SAS Viya 2026.03 release (April 2026), SAS Institute introduced PROC R as an official procedu...
A Three-Tier Framework: Global, Standard, and Analysis Macros Abstract SAS macros are the engineering backbone of clinical statistical programming. When designed well, they accelerate delivery, enforce consistency across studies, a...
EAER vs EAIR - A Deep Dive for Statistical Programmers 1. Why Exposure Adjustment Matters In a clinical trial, patients rarely spend the same amount of time under observation. Some drop out early, some experience an event on day 3, som...
A Deep Dive Guide for Statistical Programmers Understanding Your Role from IND to Approval Covers Pre-IND through NDA/BLA Approval CDER Data Standards • SDSP • End-of-Phase Meetings • Interim Analyses • Advisory Committees...
A Deep-Dive Comparison for Clinical Trials and Regulatory Data Science 1. Introduction For statistical programmers working in clinical trials, the analytical landscape has historically centered on SAS. That dominance is now being chall...
Deep Dive Series - From Fundamentals to Advanced Clinical Trial Applications 1. Why Regression Matters for Statistical Programmers Regression analysis is the quantitative backbone of nearly every efficacy and safety analysis in clini...
A clinstandards.org Deep-Dive · For Statistical Programmers in Clinical Trials Introduction: Two Worlds, One Submission A Phase 3 clinical trial is the most expensive, most complex, and highest-stakes undertaking in the pharmaceutical...
USPI, DTS, SmPC, CT.gov, and the Final Push to Drug Approval Deep Dive Series — CDISC Open Source Ecosystem clinstandards.org | Published: March 2026 Abstract The period between submission acceptance and drug approval is among t...
Deep Dive Series — CDISC Open Source Ecosystem clinstandards.org | Published: March 2026 Abstract CDISC has an active public review open for ADaM Questionnaire, Ratings, and Scales (QRS) supplements to the ADaMIG — currently featur...
A Practical Guide to the Science, Data Standards, and ADaM Implementation Deep Dive Series — CDISC Open Source Ecosystem clinstandards.org | Published: March 2026 Abstract RECIST 1.1 (Response Evaluation Criteria in Solid Tumors...
The Statistical Programmer's Deep Dive into P-Values, Confidence Intervals & Hypothesis Testing A Practical Guide with Clinical Trial Examples Across Six Therapeutic Areas 1. Introduction: Why This Matters to You As a stat...
What This Article Covers: This deep dive examines TFL Designer — the CDISC COSA-approved, open-source platform available at tfldesigner.org — from first principles. We trace its origins in the industry-wide problem of manual TFL shell...
Introduction For years, statistical programmers in the pharmaceutical industry have grappled with one of the most labor-intensive tasks in the clinical submission workflow: creating Study Data Tabulation Model (SDTM) datasets from raw c...
Introduction If you are a statistical programmer in the pharmaceutical industry, you have likely watched the rise of machine learning and deep learning with a mixture of curiosity and apprehension. The terminology sounds foreign — neural...
Introduction The Analysis Data Model (ADaM) is a foundational CDISC standard that defines the structure and content of analysis-ready datasets required for regulatory submissions to the FDA and other global health authorities. For elect...
Understanding the Electronic Submissions Gateway Validation Process Executive Summary The FDA’'s Technical Rejection Criteria (TRC) represent a critical set of automated validation rules that determine whether clinical and nonc...
The ICH Framework, Global Regulators, and What Statistical Programmers Should Know 1. Introduction: Why the Upstream Architecture Matters Most statistical programmers enter the clinical data world through SDTM, ADaM, and Define-X...
How Open-Source Innovation Is Reshaping Standards Compliance in Clinical Research Introduction For over two decades, the clinical research industry has relied on CDISC standards to bring consistency, quality, and regulatory complianc...
1. Why ARM Matters: Executive Summary for Decision-Makers For organizations submitting clinical trial data to both FDA and PMDA, Analysis Results Metadata has evolved from a "nice to have" enhancement to a strategic component...
1. The Problem We're Solving
If you're a statistical programmer, your daily workflow probably looks something like this:
Someone emails or FTPs you a data extract. Or you download it from a shared drive.
You copy the files...
What Statistical Programmers Need to Know About the Biggest SDTM Update in Years The Biggest SDTM Overhaul Since 2004 CDISC is preparing to release the most significant update to its foundational tabulation standards since the mode...
After more than 35 years of relying on SAS V5 XPORT (XPT) files for regulatory submissions, the clinical data landscape is on the cusp of a transformative change. CDISC Dataset-JSON v1.1 is poised to become the new standard for electronic...
As FDA submissions evolve toward greater standardization, traceability, and automation, sponsors are increasingly challenged to operationalize USDM , Analysis Results Standard (ARS) , and define.xml 2.1 in a cohesive, scalable manner...
The role of the Statistical Programmer is evolving. We are no longer just writing code—we are designing systems, defining intent, and validating outcomes . As AI tools become embedded in clinical data workflows, the competitive advant...
The FDA recently updated the Data Standards Catalog, and for clinical programmers, this is a significant shift. The Catalog — a deceptively simple spreadsheet published on the FDA’s Study Data Standards Resources page — is the authoritativ...
From Documents to Data
The Current State: Protocol as PDF
Today’s clinical trial lifecycle typically starts with a
PDF protocol :
Study objectives described in prose
Endpoints buried in text
Visit schedules embed...
